This manuscript presents structural and biochemical studies of the Paf1C multi-protein complex (Paf1, Leo1, Ctr9, Rtf1, Cdc73) from S. cerevisiae: a Pol II transcription elongation factor with additional roles in chromatin remodeling and mRNA processing. First, the recombinant bacterial expression and purification of the Paf1C complex is shown, and pull-down experiments demonstrate an interaction with Pol II, which is enhanced in the presence of TFIIS. Next, the cryo-EM structure of a crosslinked Pol II-Paf1C-TFIIS complex is presented. The density for Paf1C is a low-resolution composite of three independently-refined 3D classes, and to aid interpretation, chemical crosslinking coupled to mass spectrometry (XL-MS) is performed. Because the observed density for Paf1C clashes with the known structure of the Pol II-TFIIF initiation complex, the authors propose a model in which TFIIF and Paf1C compete for binding to Pol II, and conduct assays to demonstrate this. Finally the authors demonstrate the importance of Paf1C in vivo by using 4tU-Seq experiments to show a global decrease in mRNA synthesis in ΔPaf1 and ΔRtf1 yeast strains.
1.
The assertion that the Paf1C -Pol II interaction is "strongly enhanced by TFIIS" (line 134) is not supported by the data. Based on Fig. S2a , comparing lanes 4 and 5 this appears to be the case, but in Fig. S2b , the equivalent lanes 6 and 8 show no such difference. Similarly, in there isn't a striking difference in binding when TFIIS is present (line 132). This leads me to question the reproducibility of these pull-downs. Technical replicates accompanied by band quantification and an analysis of statistical significance would clarify this.
Related to the point above, the authors state that the TFIIS-ΔN130 construct "could not enhance the Pol II-Paf1C interaction" (line 128). However, in Fig. S2b lane 6 and 7 appear to show that TFIIS-ΔN130 actually inhibits the interaction slightly. Again, it would be good to see replicates to know if this small difference is statistically significant.
2.
The "three-lobed" (A, B, C) model presented in Fig. 3 , 5 and 7 is not actually a cryo-EM structure. It is a composite of three structures of Pol II, each with a different "lobe", obtained by 3D classification -the real structural result of the paper is shown in Supplementary Figures 4 and 5. It is therefore potentially misleading to combine the three "lobes" and present them as continuous Paf1C density without any direct structural evidence that this is the case. (e.g. why do lobes A and B and C never occur in the same 3D class?). The authors state that "their relative orientation is flexible…due to mobility on the Pol II surface" (line 170) -if this is true, the relevance of the presented structure is unclear. During the discussion of XL-MS data, the authors state (line 234) "Ctr9 did not crosslink effectively to Pol II, consistent with the bridging density B that does not reach the Pol II surface." If density B does not contact Pol II, how can it form a stable 3D class in the absence of densities A and C providing the Pol II interactions?
One possible explanation for A, B and C densities being observed independently is that the complex falls apart during vitrification of EM grids -a common problem in the field. I assume that stability was a problem because crosslinking was performed prior to cryo-EM. A negative stain EM dataset should provide a low-resolution 3D reconstruction that would help validate the cryo-EM maps and demonstrate that lobes A, B and C actually do form continuous density corresponding to Paf1C. Indeed, the authors state that negative stain EM was performed (line 144) but never show any micrographs or 2D classes. A negative stain 3D model would make the proposed cryo-EM model much more convincing, given the problems mentioned above.
3.
Whilst the XL-MS gives valuable insight into the Paf1C-Pol II interconnectivity, there is insufficient evidence for assigning any proteins to the cryo-EM densities without more evidence that the densities can co-exist in a continuous manner, especially since the masses of the individual proteins do not correspond to the sizes of the observed lobes. As such, the discussion in lines 235 -242 should be removed or substantially reworded.
4.
The authors conclude from sucrose gradient experiments (Fig. 5 ) that Paf1C and TFIIF bind to Pol II in a competitive manner. However, my interpretation of Fig. 5 is that TFIIF binds more tightly to Pol II and can displace Paf1C, whereas Paf1C cannot effectively displace TFIIF. This explanation is actually more consistent with the idea that Paf1C lobe A region is flexible and can occupy multiple positions on the Pol II surface -one would not expect such a protein to be able to compete off a tightly bound factor (TFIIF) at a specific site. Pull-down experiments with different competitor concentrations could help clarify the relative affinities and show whether binding is really mutually exclusive.
5.
The 4tU-seq experiments presented in Fig. 6 effectively show that ΔPaf1 and ΔRtf1 strains have defects in mRNA synthesis. However, the authors do not show that this decrease is unique to Pol II transcripts. Control analyses looking at relative abundance of Pol III transcripts in the WT and knockout strains would strengthen this.
Minor:
1.
The statement is often made that the five Paf1C subunits are present in approximately stoichiometric amounts, yet Leo1 often appears sub-stoichiometric (e.g. Fig. 2) . What is the reason for this? It is surprising as this is the subunit that crosslinks to Rpb2 the most. Fig 4a shows that most of the Pol II-Paf1C crosslinks map to a 100 amino acid stretch of Leo1. This is the same region of Leo1 that forms most of the intra-Paf1C crosslinks also. Is this region of Leo1 particularly notable, e.g. disordered/flexible/lysine-rich? This relative crosslinking promiscuity (compared to the other Paf1C subunits) should be discussed more in the text.
2.
It was unclear what the rationale was for making the various truncation mutations, and how the mutations were chosen (Lines 115 -118). Were these constructs necessary to optimize expression/improve solubility/reduce degradation? The pull-down experiments in Supplementary  Fig. 2 were not conducted with the core Paf1C.
A reference to Fig S1 on Line 176 would help.
3. Supplementary Fig. 3 seems like a logical extension of Fig. 2 , and could be combined into the same figure. The legend in this figure should include more details about the conditions of image acquisition e.g. K2 camera, magnification, dose.
It would also be good to include representative negative stain micrographs, 2D classes and a 3D reconstruction here, or as a separate figure.
4.
The individual lobe structures presented in Supplementary Fig. 4 or 5 should be moved to the main article, in Fig. 3 , as these are the main EM results of the paper. The merged "threelobed" structures shown in Fig. 3 , 5 and 7 represent an interpretation of the three separate structures and should be defined as such. Do volumes A, B and C clash or overlap with each other when merged to generate the composite?
5.
To present the cross-linking data (Figure 4d ), it would be better to show the crystal structure of Pol II with crosslinked residues highlighted. This would allow the reader to identify surface patches that interact with each of the Paf1C subunits. The locations of the three separate cryo-EM lobes could be indicated beside the structure as panels allowing visualization of the relative proximity of the crosslinked Pol II residues to the separate blobs of EM density.
6.
The phrase "movie stacks" should be replaced with "micrographs" (line 145).
7.
The colors in Fig. 5a should be changed: Both Paf1C density and TFIIF subunits are different shades of pink/purple, which is confusing.
8.
The resolutions listed in lines 156 and 160 are misleading, as this only refers to the Pol II core (see Supplementary Fig. 5e-g ). The actual resolutions for densities A, B and C are more like 10 -20 Å. This should be clearly stated in the text.
9.
Referring to Cdc73, the authors state "we could fit this crystal structure to the globular density" (line 227), but the actual fit is not shown (apart from an outline in Fig. 4d .) A figure should be included to show this fit in 3D.
10.
The statement in the discussion "thus our results elucidate the general transcription cycle" (line 289) should be removed.
11.
Typo (line 724) "starting form"
12.
In the legend for Fig. 3 (line 844) the authors state "The same threshold level in Chimera was used to contour densities". It is unclear to what densities this refers -A, B, C and Pol II? Or just A, B and C? It looks like Pol II is displayed at a different threshold to the other densities.
13.
In Fig. 4d , it would be useful to include an approximate measure of length on the indicated crosslinks.
Reviewer #2 (Remarks to the Author):
In this study, Xu et al. use cryo-electron microscopy, chemical crosslinking/mass spectrometry, and protein binding studies to investigate the structure of the yeast Paf1C bound to Pol II and TFIIS. Paf1C has been implicated in regulating chromatin structure during transcription elongation but little is known about this conserved complex at the structural level. Through their cryo-EM analysis, the authors provide the first structural insights into the Paf1 complex and its interactions with Pol II. This is an important contribution to the transcription/chromatin field, as previous crystallography studies focused on small functional domains in Paf1C. Other conclusions from this work indicate that the elongation factor TFIIS can enhance Paf1C association with Pol II and that the initiation factor TFIIF may preclude binding of Paf1C to Pol II through a steric clash. Nascent transcript profiling studies support an important role for Paf1C in global regulation of transcription; however, the impact of this part of the paper is limited by the analysis that was performed. Overall, the primary strength of this paper is the cryo-EM structure of Paf1C and its association with Pol II and TFIIS. The other contributions of the paper are weaker primarily because the data indicate somewhat subtle effects that were analyzed by only a single approach or because the results were not fully analyzed.
1.
The introduction is not very well written. It reads like a list of facts with insufficient cohesion.
2.
The supplemental figures are cited out of order. The figures should be re-formatted accordingly.
3.
There is insufficient information on how the limited proteolysis data were analyzed to define the core Paf1C.
4.
The term "synergistic" seems inappropriate when describing enhanced binding of Paf1C in the presence of TFIIS. Does Paf1C enhance the binding of TFIIS?
5.
Supplementary Figure 2C : The authors report enhanced binding of Paf1C derivatives in the presence of TFIIS. This is very difficult to see in the figures provided. The bands in this and other gels are faint, making comparisons very difficult. Putting the overall faintness of the gel aside, I do not see a significant difference in Paf1C subunit levels between reactions containing TFIIS and those lacking TFIIS. Ctr9 and Cdc73 levels look nearly identical among the four samples in lanes 6-9. Moreover, coomassie staining is not a very quantitative measure of protein abundance.
6.
The assignment of specific subunits to the three Paf1C parts (A, B, and C) was guided by chemical crosslinking data. Do the authors have any other information to verify the assignments? For example, Ctr9 is assigned to part B because it crosslinks to Paf1/Leo1 (assigned to A) and Cdc73 (assigned to B). This seems logical but the same argument could be made for Rtf1, which is not assigned to any part of the structure.
7.
Can the authors fit the Paf1-Leo1 crystal structure into Paf1C part A?
8. Qiu et al. reported that Cdc73 binds to the CTD of Rpb1. The authors do not address this interaction in their structure or in their description of the model.
9.
The conclusion that binding of TFIIF to Pol II impedes the binding of Paf1C due to a steric class is intriguing and supports the notion that transition from initiation to elongation is controlled by an exchange of Pol II-bound factors. However, the data for this are not especially strong. In panels 5B and 5C, binding of Paf1C and TFIIF do not appear mutually exclusive. Moreover, the staining is faint and not quantitative. In the absence of additional biochemical or functional data, the conclusion of a competition between TFIIF and Paf1C is not yet convincing. A more minor point: the figures could be made clearer by using colors other than shades of purple/pink for both Paf1C and TFIIF.
10.
The 4tU-seq data do not add very much to the paper. They are under-analyzed and appear to be tacked on. I would recommend omitting the data or providing a more complete analysis. Also, do the authors have an explanation for why the rtf1 mutant would show a greater decrease in mRNA levels than the paf1 mutant? For many phenotypes, paf1 mutants are more severely compromised than rtf1 mutants.
11.
How was the spike-in normalization carried out? More details would be helpful.
12.
Line 58: "Paf1C" should replace "Paf1"
13. Lines 203-206: The finding of a crosslink between Leo1 and TFIIS is new and interesting. However, with the current writing, the authors suggest it provides a "positive control".
14.
Line 214: What is the evidence for a "subassembly" involving Paf1-Leo1-Ctr9?
15. 17. Supplementary Figure 1a legend: "Crt9" should be changed to "Ctr9".
18.
Abstract: Although Paf1C is clearly important for mRNA transcription, the term "required for mRNA transcription" is a bit strong. Yeast cells lacking the complex are viable. This manuscript presents structural and biochemical studies of the Paf1C multiprotein complex (Paf1, Leo1, Ctr9, Rtf1, Cdc73) from S. cerevisiae: a Pol II transcription elongation factor with additional roles in chromatin remodeling and mRNA processing. First, the recombinant bacterial expression and purification of the Paf1C complex is shown, and pull-down experiments demonstrate an interaction with Pol II, which is enhanced in the presence of TFIIS. Next, the cryo-EM structure of a crosslinked Pol II-Paf1C-TFIIS complex is presented. The density for Paf1C is a lowresolution composite of three independently-refined 3D classes, and to aid interpretation, chemical crosslinking coupled to mass spectrometry (XL-MS) is performed. Because the observed density for Paf1C clashes with the known structure of the Pol II-TFIIF initiation complex, the authors propose a model in which TFIIF and Paf1C compete for binding to Pol II, and conduct assays to demonstrate this. Finally the authors demonstrate the importance of Paf1C in vivo by using 4tU-Seq experiments to show a global decrease in mRNA synthesis in ΔPaf1 and ΔRtf1 yeast strains.
In general, the paper is well written and figures are clearly presented, and the topic is of particular interest to the transcription and RNA processing communities. This complex was obviously technically very challenging and did not lend itself well to structure determination by cryo-EM; such an ambitious effort is therefore commendable. Overall, the main finding is identification of Paf1C binding sites on Pol II, and how Paf1C binding impacts other Pol II interaction partners. However, too much emphasis is placed on the cryoEM structure and several key conclusions are not justified based on the presented data. The results and discussion should be re-written in light of this, and further experiments should be performed to validate and extend the structural aspects of the work. In particular, the following points should be addressed.
We thank the reviewer for the kind words and helpful comments.
Major: 1. The assertion that the Paf1C -Pol II interaction is "strongly enhanced by TFIIS" (line 134) is not supported by the data. Based on Fig. S2a , comparing lanes 4 and 5 this appears to be the case, but in Fig. S2b , the equivalent lanes 6 and 8 show no such difference. Similarly, in Fig. S2c (lanes 6-9) there isn't a striking difference in binding when TFIIS is present (line 132). This leads me to question the reproducibility of these pull-downs. Technical replicates accompanied by band quantification and an analysis of statistical significance would clarify this.
We observed highly similar results when we repeated these pull-down assays. To make it clear, we quantified the bands using Image J to visualize the change. We now added quantified Leo1/Rpb4 fold change in Supplementary Fig. 2. In Fig. S2d , error bars indicate the standard error of the mean from 3 replicates.
2. The "three-lobed" (A, B, C) model presented in Fig. 3 , 5 and 7 is not actually a cryo-EM structure. It is a composite of three structures of Pol II, each with a different "lobe", obtained by 3D classification -the real structural result of the paper is shown in Supplementary Figures 4 and 5 . It is therefore potentially misleading to combine the three "lobes" and present them as continuous Paf1C density without any direct structural evidence that this is the case. (e.g. why do lobes A and B and C never occur in the same 3D class?). The authors state that "their relative orientation is flexible…due to mobility on the Pol II surface" (line 170) -if this is true, the relevance of the presented structure is unclear. During the discussion of XL-MS data, the authors state (line 234) "Ctr9 did not crosslink effectively to Pol II, consistent with the bridging density B that does not reach the Pol II surface." If density B does not contact Pol II, how can it form a stable 3D class in the absence of densities A and C providing the Pol II interactions?
We apologize that this may have led to misunderstandings. In our initial 3D reconstruction of the Pol II-Paf1C-TFIIS complex from 57% of the cleaned data set, we observe, at lower resolution, continuous density for all 3 parts of the Paf1C. To clarify this, we have added the continuous density to Fig. 2. In Fig. 2C, a 3. Whilst the XL-MS gives valuable insight into the Paf1C-Pol II interconnectivity, there is insufficient evidence for assigning any proteins to the cryo-EM densities without more evidence that the densities can co-exist in a continuous manner, especially since the masses of the individual proteins do not correspond to the sizes of the observed lobes. As such, the discussion in lines 235 -242 should be removed or substantially reworded.
In the global reconstruction shown in Fig. 2C (see above) there is a continuous density of Paf1C, indicating that the densities coexist. Indeed, it is difficult to assign any individual proteins to the density lobes due to the flexibility of the subunits and the low resolution, but the XL-MS does indicate the location of Paf1C regions within these densities.
4. The authors conclude from sucrose gradient experiments (Fig. 5 ) that Paf1C and TFIIF bind to Pol II in a competitive manner. However, my interpretation of Fig. 5 is that TFIIF binds more tightly to Pol II and can displace Paf1C, whereas Paf1C cannot effectively displace TFIIF. This explanation is actually more consistent with the idea that Paf1C lobe A region is flexible and can occupy multiple positions on the Pol II surface -one would not expect such a protein to be able to compete off a tightly bound factor (TFIIF) at a specific site. Pull-down experiments with different competitor concentrations could help clarify the relative affinities and show whether binding is really mutually exclusive. Fig. 6 Minor: 1. The statement is often made that the five Paf1C subunits are present in approximately stoichiometric amounts, yet Leo1 often appears sub-stoichiometric (e.g. Fig. 2) . What is the reason for this? It is surprising as this is the subunit that crosslinks to Rpb2 the most. Fig 4a shows that most of the Pol II-Paf1C crosslinks map to a 100 amino acid stretch of Leo1. This is the same region of Leo1 that forms most of the intra-Paf1C crosslinks also. Is this region of Leo1 particularly notable, e.g. disordered/flexible/lysine-rich? This relative crosslinking promiscuity (compared to the other Paf1C subunits) should be discussed more in the text. 
We agree with the reviewer that the binding of TFIIF to Pol II is stronger than the binding of Paf1C to Pol II. To directly show this, we have now included a native PAGE gel to analyze sucrose gradient fractions. This shows that TFIIF can almost entirely compete out the Pol II-bound Paf1C, but not the other way around. We thank the reviewer for the suggestion and think this aspect is now much improved and clarified. We nevertheless agree with the reviewer that the binding may not be mutually exclusive, in particular when other factors are additionally present in cells, and we have modified the text accordingly.

The 4tU-seq experiments presented in
Full-length Leo1 is not as stable as the other proteins in the
2.
It was unclear what the rationale was for making the various truncation mutations, and how the mutations were chosen (Lines 115 -118). Were these constructs necessary to optimize expression/improve solubility/reduce degradation? The pulldown experiments in Supplementary Fig. 2 were not conducted with the core Paf1C. We have added a reference to Fig. S1 on Line 176.
The original idea for the various truncations was to remove flexible regions for crystallization trials. First we purified the full-length Paf1C. Then the limited proteolysis coupled to Edman sequencing showed the C-terminal region of
3. Supplementary Fig. 3 seems like a logical extension of Fig. 2 , and could be combined into the same figure. The legend in this figure should include more details about the conditions of image acquisition e.g. K2 camera, magnification, dose. It would also be good to include representative negative stain micrographs, 2D classes and a 3D reconstruction here, or as a separate figure.
We have added a negative-stain micrograph to Supplementary Fig. 3 , and a 3D reconstruction of Pol II-Paf1C-TFIIS EC in Fig. 2 , to address this point. We now have included more details about the conditions of image acquisition to the Supplementary Fig. 3 . Supplementary Fig. 4 or 5 should be moved to the main article, in Fig. 3 , as these are the main EM results of the paper. The merged "three-lobed" structures shown in Fig. 3 , 5 and 7 represent an interpretation of the three separate structures and should be defined as such. Do volumes A, B and C clash or overlap with each other when merged to generate the composite?
The individual lobe structures presented in
We would be happy to move Supplementary Fig. 4 5. To present the cross-linking data (Figure 4d ), it would be better to show the crystal structure of Pol II with crosslinked residues highlighted. This would allow the reader to identify surface patches that interact with each of the Paf1C subunits. The locations of the three separate cryo-EM lobes could be indicated beside the structure as panels allowing visualization of the relative proximity of the crosslinked Pol II residues to the separate blobs of EM density.
We have included the Supplementary Fig. 6 showing the highlighted crosslinked residues on Pol II-TFIIS EC structure. In this figure, we also summarized the crosslinked lysine residues of Paf1C.
6. The phrase "movie stacks" should be replaced with "micrographs" (line 145).
We have changed the text accordingly. Fig. 5a should be changed: Both Paf1C density and TFIIF subunits are different shades of pink/purple, which is confusing.
The colors in
To be consistent with our previous publications, we would like to leave TFIIF subunits in plum and medium purple. But we rendered the ribbon model of TFIIF in a different way to make it more visible.
8. The resolutions listed in lines 156 and 160 are misleading, as this only refers to the Pol II core (see Supplementary Fig. 5e-g ). The actual resolutions for densities A, B and C are more like 10 -20 Å. This should be clearly stated in the text.
We now have stated this in the text.
9. Referring to Cdc73, the authors state "we could fit this crystal structure to the globular density" (line 227), but the actual fit is not shown (apart from an outline in Fig. 4d.) A figure should be included to show this fit in 3D.
We have now replaced the outline of Paf1C density with the EM density in Fig.4d . This shows the fit nicely.
10. The statement in the discussion "thus our results elucidate the general transcription cycle" (line 289) should be removed.
We have rephrased this but wish to maintain the take-home message that the structure helps to explain factor exchange on the Pol II surface, i.e. progression through the transcription cycle.
11. Typo (line 724) "starting form"
OK.
12. In the legend for Fig. 3 (line 844 ) the authors state "The same threshold level in Chimera was used to contour densities". It is unclear to what densities this refers -A, B, C and Pol II? Or just A, B and C? It looks like Pol II is displayed at a different threshold to the other densities.
We used Pol II as an indication to put the same threshold. Pol II, A, B, and C are at the same threshold. Because the three reconstitutions were locally filtered and renormalized and Pol II has much better resolution, so it looks at a different threshold than the densities from Paf1C. We have now stated this in the legend of Fig. 3. 13. In Fig. 4d , it would be useful to include an approximate measure of length on the indicated crosslinks.
We now have included distances between crosslink sites on the Cdc73 GTPase-like domain and Rpb3/Rpb11.
Reviewer #2 (Remarks to the Author):
In this study, Xu et al. use cryo-electron microscopy, chemical crosslinking/mass spectrometry, and protein binding studies to investigate the structure of the yeast Paf1C bound to Pol II and TFIIS. Paf1C has been implicated in regulating chromatin structure during transcription elongation but little is known about this conserved complex at the structural level. Through their cryo-EM analysis, the authors provide the first structural insights into the Paf1 complex and its interactions with Pol II. This is an important contribution to the transcription/chromatin field, as previous crystallography studies focused on small functional domains in Paf1C. Other conclusions from this work indicate that the elongation factor TFIIS can enhance Paf1C association with Pol II and that the initiation factor TFIIF may preclude binding of Paf1C to Pol II through a steric clash. Nascent transcript profiling studies support an important role for Paf1C in global regulation of transcription; however, the impact of this part of the paper is limited by the analysis that was performed. Overall, the primary strength of this paper is the cryo-EM structure of Paf1C and its association with Pol II and TFIIS. The other contributions of the paper are weaker primarily because the data indicate somewhat subtle effects that were analyzed by only a single approach or because the results were not fully analyzed. Supplementary Fig.2 , a native PAGE analysis in Fig.5 , and further analysis of 4tU-seq in Fig.6 to strengthen our conclusion. Figure 2C: The authors report enhanced binding of Paf1C derivatives in the presence of TFIIS. This is very difficult to see in the figures provided. The bands in this and other gels are faint, making comparisons very difficult. Putting the overall faintness of the gel aside, I do not see a significant difference in Paf1C subunit levels between reactions containing TFIIS and those lacking TFIIS. Ctr9 and Cdc73 levels look nearly identical among the four samples in lanes 6-9. Moreover, coomassie staining is not a very quantitative measure of protein abundance.
We thank the reviewer for the thorough review and highly appreciate the comments and suggestions. We now have included the statistical analysis of Pol II-Paf1C-TFIIS binding assays in
Supplementary
To make this clearer, we quantified the bands using Image J to visualize the change. We now added quantified Leo1/Rpb4 fold change from 3 replicates in Supplementary  Fig.2 . In Fig. S2d , error bars indicate the standard error of the mean from 3 replicates.
6. The assignment of specific subunits to the three Paf1C parts (A, B, and C) was guided by chemical crosslinking data. Do the authors have any other information to verify the assignments? For example, Ctr9 is assigned to part B because it crosslinks to Paf1/Leo1 (assigned to A) and Cdc73 (assigned to B). This seems logical but the same argument could be made for Rtf1, which is not assigned to any part of the structure.
We assigned Ctr9 to part B because it crosslinks to Paf1/Leo1 and Cdc73, and is located in between those (Fig. 4) . Rtf1 doesn't crosslink to Cdc73, thus it is difficult to assign it to density B. In our old Fig. 4 9. The conclusion that binding of TFIIF to Pol II impedes the binding of Paf1C due to a steric class is intriguing and supports the notion that transition from initiation to elongation is controlled by an exchange of Pol II-bound factors. However, the data for this are not especially strong. In panels 5B and 5C, binding of Paf1C and TFIIF do not appear to be mutually exclusive. Moreover, the staining is faint and not quantitative. In the absence of additional biochemical or functional data, the conclusion of a competition between TFIIF and Paf1C is not yet convincing. A more minor point: the figures could be made clearer by using colors other than shades of purple/pink for both Paf1C and TFIIF. 10. The 4tU-seq data do not add very much to the paper. They are under-analyzed and appear to be tacked on. I would recommend omitting the data or providing a more complete analysis. Also, do the authors have an explanation for why the rtf1 mutant would show a greater decrease in mRNA levels than the paf1 mutant? For many phenotypes, paf1 mutants are more severely compromised than rtf1 mutants.
We now have included the analysis of significantly repressed transcripts in ∆Paf1 and ∆Rtf1 strains with the use of a Venn diagram. This analysis shows most repressed transcripts in the ∆Paf1 strain are affected in the ∆Rtf1 strain, but the ∆Rtf1 stain has also 35% uniquely repressed genes, supporting the idea that Rtf1 has independent roles in transcription elongation (Cao. et. al, 2015 , Mol. Cell. Biol. doi:10.1128 11. How was the spike-in normalization carried out? More details would be helpful.
We now have added more details to explain this. 12. Line 58: "Paf1C" should replace "Paf1"
OK.
We have changed the text to make this more appealing.
14. Line 214: What is the evidence for a "subassembly" involving Paf1-Leo1-Ctr9?
The crosslinking results show the proximity of Ctr9 and the Paf1-Leo1 dimer. Additionally, we expressed and purified the Ctr9-Paf1-Leo1 trimer. We now included this into Supplementary Fig. 1 .
15. Figure 1: The black underlines are difficult to see. The diagram of Cdc73 should be corrected to read "GTPase-like domain".
We now have modified this figure accordingly.
16. Figure 2A : What do the curved lines at the bottom of the marker lane represent?
These curved lines were from a bubble during the gel scanning. To avoid the confusion, we now have removed this lane. Figure 1a legend: "Crt9" should be changed to "Ctr9".
Supplementary
OK.
18. Abstract: Although Paf1C is clearly important for mRNA transcription, the term "required for mRNA transcription" is a bit strong. Yeast cells lacking the complex are viable.
We do not wish to substantially change this, but we reworded "required for mRNA transcription" to "required for normal mRNA transcription". 
